Enveric Biosciences (ENVB) Current Assets (2010 - 2026)
Enveric Biosciences (ENVB) reported Current Assets of $8.79 million for Q2 2026, up 165.9% from $3.31 million a year earlier and up 63.6% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Enveric Biosciences posted Current Assets of $4.94 million, up 80.5% from FY2024.
- Current Assets has a five-year compound annual growth rate of 16.7% (FY2020 to FY2025).
- By year, Current Assets came in at $2.73 million in FY2024 (-23.6%), $3.58 million in FY2023 (-80.6%), $18.43 million in FY2022 (+3.9%) and $17.74 million in FY2021 (+678.2%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets since Q2 2023.
- Year over year, Current Assets has now increased in each of the last three quarters, with growth averaging 15.4% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q4 2021 (growth of 678.2%); the low point was Q4 2023 (a decline of 80.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.38 million (Q1 2026), $4.94 million (Q4 2025) and $4.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | 8.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.79 Mn |
| Mar 31, 2026 | 5.38 Mn |
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.17 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 4.83 Mn |
| Dec 31, 2024 | 2.73 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | 5.52 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 5.83 Mn |
| Jun 30, 2023 | 8.90 Mn |
| Mar 31, 2023 | 14.84 Mn |
| Dec 31, 2022 | 18.43 Mn |
| Sep 30, 2022 | 22.27 Mn |
| Jun 30, 2022 | 19.37 Mn |
| Mar 31, 2022 | 22.67 Mn |
| Dec 31, 2021 | 17.74 Mn |
| Sep 30, 2021 | 22.28 Mn |
API Access
Enveric Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();